RotaTeq® is a vaccine indicated for the prevention of rotavirus gastroenteritis caused by types G1, G2, G3, G4, and G9
RotaTeq is approved for use in infants 6 weeks to 32 weeks of age
The vaccination series consists of three ready-to-use liquid doses of RotaTeq* administered orally starting at 6 to 12 weeks of age, with the subsequent doses administered at 4 to 10 week intervals
Each dose is supplied in a container consisting of a squeezable plastic dosing tube with a twist-off cap, allowing for direct oral administration
The dosing tube is contained in a pouch
Package of 25 individually pouched single-dose tubes
Manufacturer # 00006404720
Brand RotaTeq®
Manufacturer Merck
Country of Origin United States
Application Rotavirus Vaccine
Container Type Single-Dose Tube
Dosage Form Solution
Generic Drug Code 26500
Generic Drug Name Rotavirus Vaccine, Live, Oral Pentavalent
Is_Active_Vendor Y
Is_DSCSA Y
Is_Discontinued N
Is_Medical_Device Y
Lot_Tracking_Flag Y
NDC Number 00006404720
On_Allocation N
Product Dating McKesson Acceptable Dating: we will ship >= 90 days
Storage Requirements Requires Refrigeration
Supplier_ID 3885337
Type Oral
UNSPSC Code 51201618
User Indicated for People 6 to 32 Weeks of Age
Volume 2 mL
